These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3113462)

  • 1. Therapy of acquired immune deficiency syndrome with recombinant interleukin-2.
    Volberding P; Moody DJ; Beardslee D; Bradley EC; Wofsy CB
    AIDS Res Hum Retroviruses; 1987; 3(2):115-24. PubMed ID: 3113462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of epidemic Kaposi's sarcoma. Implications for therapy.
    Mitsuyasu RT; Taylor JM; Glaspy J; Fahey JL
    Cancer; 1986 Apr; 57(8 Suppl):1657-61. PubMed ID: 3081246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exacerbation of epidemic Kaposi's sarcoma with a combination of interleukin-2 and beta-interferon: results of a phase 2 study.
    Krigel RL; Padavic-Shaller KA; Rudolph AR; Poiesz BJ; Comis RL
    J Biol Response Mod; 1989 Aug; 8(4):359-65. PubMed ID: 2666585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's sarcoma and the acquired immune deficiency syndrome. Treatment with recombinant interferon alpha and analysis of prognostic factors.
    Krown SE; Real FX; Vadhan-Raj S; Cunningham-Rundles S; Krim M; Wong G; Oettgen HF
    Cancer; 1986 Apr; 57(8 Suppl):1662-5. PubMed ID: 3081247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
    Pellet C; Chevret S; Blum L; Gauvillé C; Hurault M; Blanchard G; Agbalika F; Lascoux C; Ponscarme D; Morel P; Calvo F; Lebbé C
    J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological characterizations of patients with acquired immune deficiency syndrome, acquired immune deficiency syndrome-related symptom complex, and a related life-style.
    Hersh EM; Mansell PW; Reuben JM; Rios A; Newell GR
    Cancer Res; 1984 Dec; 44(12 Pt 1):5894-901. PubMed ID: 6209006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon.
    Real FX; Oettgen HF; Krown SE
    J Clin Oncol; 1986 Apr; 4(4):544-51. PubMed ID: 3958767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological variables as predictors of prognosis in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome.
    Vadhan-Raj S; Wong G; Gnecco C; Cunningham-Rundles S; Krim M; Real FX; Oettgen HF; Krown SE
    Cancer Res; 1986 Jan; 46(1):417-25. PubMed ID: 2415251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acquired immunodeficiency syndrome--related Kaposi's sarcoma with lymphoblastoid interferon.
    Rios A; Mansell PW; Newell GR; Reuben JM; Hersh EM; Gutterman JU
    J Clin Oncol; 1985 Apr; 3(4):506-12. PubMed ID: 3872349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors.
    Bosly A; Guillaume T; Brice P; Humblet Y; Staquet P; Doyen C; Chatelain B; Franks CR; Gisselbrecht C; Symann M
    Exp Hematol; 1992 Sep; 20(8):962-8. PubMed ID: 1354620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion of activated T-lymphocytes in patients treated with recombinant interleukin 2.
    Kolitz JE; Welte K; Wong GY; Holloway K; Merluzzi VJ; Engert A; Bradley EC; Konrad M; Polivka A; Gabrilove JL
    J Biol Response Mod; 1987 Aug; 6(4):412-29. PubMed ID: 3498011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
    Gill PS; Espina BM; Moudgil T; Kidane S; Esplin JA; Tulpule A; Levine AM
    Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and immunological changes in AIDS patients following adoptive therapy with activated autologous CD8 T cells and interleukin-2 infusion.
    Klimas N; Patarca R; Walling J; Garcia R; Mayer V; Moody D; Okarma T; Fletcher MA
    AIDS; 1994 Aug; 8(8):1073-81. PubMed ID: 7986402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of and in vitro response to interleukin 2 in the acquired immunodeficiency syndrome.
    Murray HW; Welte K; Jacobs JL; Rubin BY; Mertelsmann R; Roberts RB
    J Clin Invest; 1985 Nov; 76(5):1959-64. PubMed ID: 2997299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic approaches to patients with AIDS.
    Lane HC; Masur H; Gelmann EP; Fauci AS
    Cancer Res; 1985 Sep; 45(9 Suppl):4674s-4676s. PubMed ID: 2990706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi's sarcoma and AIDS: a variable spectrum.
    Shepherd FA; Hogg-Johnson S; Fleshner N; Read SE; Fanning MM; Johnson K; Goss P; Coates RA
    Clin Invest Med; 1989 Dec; 12(6):367-73. PubMed ID: 2612089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistent oral cryptococcosis and Kaposi's sarcoma in acquired immunodeficiency syndrome.
    Kuruvilla A; Humphrey DM; Emko P
    Cutis; 1992 Apr; 49(4):260-4. PubMed ID: 1521478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of Kaposi's sarcoma in the epidemic of AIDS.
    Safai B; Sarngadharan MG; Koziner B; Godbold J; Myskowski PL; Cunningham-Rundles S; Johnson K; Gold J; Krown S; Dupont B
    Cancer Res; 1985 Sep; 45(9 Suppl):4646s-4648s. PubMed ID: 2990700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy and alpha-interferon in the treatment of Kaposi's sarcoma associated with acquired immune deficiency syndrome.
    Shepherd FA; Evans WK; Garvey B; Read SE; Klein M; Fanning MM; Coates R
    CMAJ; 1988 Oct; 139(7):635-9. PubMed ID: 2458177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of the acquired immune deficiency syndrome-related Kaposi's sarcoma with bleomycin as a single agent.
    Lassoued K; Clauvel JP; Katlama C; Janier M; Picard C; Matheron S
    Cancer; 1990 Nov; 66(9):1869-72. PubMed ID: 1699652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.